Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
16
Number of overlapping holdings
25.8%
% of XLV's 62 holdings also in AGNG
19.5%
% of AGNG's 82 holdings also in XLV
Overlap by Weight
Sector Drift (XLV minus AGNG)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in XLV |
Weight in AGNG |
Overlap | |
---|---|---|---|---|
ELI LILLY & CO | 12.0% | 3.0% | 3.0% | |
ABBVIE INC | 5.9% | 2.9% | 2.9% | |
JOHNSON & JOHNSON | 6.8% | 2.8% | 2.8% | |
AMGEN INC | 2.8% | 2.9% | 2.8% | |
BOSTON SCIENTIFIC CORP | 2.6% | 3.7% | 2.6% |
Position Highlights (Non-Overlapping Exposures)
XLV Overweight Relative to AGNG
UNITEDHEALTH GROUP INC | 9.3% | |
ELI LILLY & CO | 9.1% | |
MERCK & CO. INC. | 5.0% | |
JOHNSON & JOHNSON | 4.0% | |
THERMO FISHER SCIENTIFIC INC | 3.9% | |
ABBOTT LABORATORIES | 3.8% | |
INTUITIVE SURGICAL INC | 3.7% | |
ABBVIE INC | 3.0% | |
DANAHER CORP | 2.9% | |
PFIZER INC | 2.8% |
XLV Underweight Relative to AGNG
WELLTOWER, INC. | -4.1% | |
CHUGAI PHARMACEUTICAL CO LTD | -3.6% | |
UCB SA | -3.2% | |
ALCON, INC. | -2.9% | |
ROCHE HOLDING AG-BR | -2.8% | |
ASTRAZENECA PLC-SPONS ADR | -2.7% | |
TERUMO CORP | -2.6% | |
CELLTRION INC | -2.5% | |
NOVO NORDISK A/S-B | -2.4% | |
VENTAS INC | -2.1% |